Dergiler / Turkish archives of pediatrics (Online) / 2021 / Cilt: 56 - Sayı: 2

Acute liver failure in newborns

Sayfa
108–114
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

In the literature, since there is a limited number of studies related to neonatal acute liver failure, prospective studies investigating the factors affecting treatment and prognosis are needed.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Acute liver failure is a condition that is defined as a sudden, complete, or nearly complete loss of liver functions without any previous liver disease, usually accompanied by encephalopathy, which can be reversible, but with a mortality rate of 55-70%.
📊
Temel Bulgular & Veri:Acute liver failure newborns is an acute liver failure in the first 28 days of life.
💡
Sonuç & Katkı:In the literature, since there is a limited number of studies related to neonatal acute liver failure, prospective studies investigating the factors affecting treatment and prognosis are needed.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Acute liver failure is a condition that is defined as a sudden, complete, or nearly complete loss of liver functions without any previous liver disease, usually accompanied by encephalopathy, which can be reversible, but with a mortality rate of 55-70%. Acute liver failure newborns is an acute liver failure in the first 28 days of life. The Pediatric Acute Liver Failure Working Group identified the presence of coagulopathy as the main finding for the identification of acute liver failure in childhood following vitamin K administration. Although the incidence of acute liver failure is reported to be 17/100 000 in all ages, its incidence is not known exactly in newborn and childhood. The most common cause of acute liver failure in the newborn period is the gestational alloimmune liver disease that was previously known as neonatal hemochromatosis. This is followed by viral infections, metabolic diseases, hemophagocytic lymphohistiocytosis, and other rare causes. In the neonatal period, acute liver failure is a rare condition with a high mortality rate. For this reason, the vital signs of the patients should be closely monitored and supportive treatments should be planned according to the follow-up and the etiology of the disease should be clarified urgently. In this process, acyclovir treatment until herpes simplex virus infection is excluded and lactose-free feeding until galactosemia is excluded are recom-mended as life-saving treatments. In the literature, since there is a limited number of studies related to neonatal acute liver failure, prospective studies investigating the factors affecting treatment and prognosis are needed.

🔖

Bu Makaleye Atıf Yap

KARADAĞ, N., GUNES, A. O., KARATEKİN, G. (2021). Acute liver failure in newborns. Turkish archives of pediatrics (Online), Cilt: 56 - Sayı: 2, 108–114. https://ajindex.com/articles/369973

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (5)

  1. Suchy FJ. Fulminant hepatic failure. In: Kleigman RM, Stanton BF, Schor NF, Behrman RE, ST. Geme JW, editors. Nelson Textbook of Pediatrics. 20th Ed. Philadelphia: W.B. Saunders; 2016. p 1966-8
  2. Squires RH, Alonso EM. Acute liver failure in children. In: Suchy FJ, Sokol RJ, Balistreri WF, editors. Liver Disease in Children. 4th Ed, Cambridge University Press, New York 2012
  3. Siew SM, Kelly DA. The Liver in the Neonate, in Infancy, and Childhood. In: Dooley JS, Lok ASF, Garcia-Tsao G, Pinzani M, editors. Sherlock’s Diseases of the Liver and Biliary System, 13th Ed; John Wiley & Sons Ltd; 2018. p 588-621. [Crossref] 4. Zozaya Nieto C, Fernández Caamaño B, Muñoz Bartolo G, et al. Presenting Features and Prognosis of Ischemic and Nonischemic Neonatal Liver Failure. J Pediatr Gastroenterol Nutr 2017; 64: 754-9. [Crossref] 5. Ciocca M, Álvarez F. Neonatal acute liver failure: a diagnosis challenge. Arch Argent Pediatr 2017; 115: 175-80. [Crossref] 6. Taylor SA, Whitington PF. Neonatal acute liver failure. Liver Transpl 2016; 22: 677-85. [Crossref] 7. Sundaram SS, Alonso EM, Narkewicz MR, Zhang S, Squires RH; Pediatric Acute Liver Failure Study Group. Characterization and outcomes of young infants with acute liver failure. J Pediatr 2011; 159: 813-8. [Crossref] 8. Jackson R, Roberts EA. Identification of neonatal liver failure and perinatal hemochromatosis in Canada. Paediatr Child Health 2001; 6: 248-50. [Crossref] 9. Casas-Alba D, Clotet J, Inarejos EJ, Jou C, Fons C, Molera C. Broadening the spectrum of neonatal hemochromatosis. J Matern Fetal Neonatal Med 2018; 10: 1-3
  4. Shanmugam NP, Bansal S, Greenough A, Verma A, Dhawan A. Neonatal liver failure: aetiologies and management-state of the art. Eur J Pediatr 2011; 170: 573-81. [Crossref] 11. Bersani I, Auriti C, Piersigilli F, et al. Neonatal acute liver failure due to enteroviruses: a 14 years single NICU experience. J Matern Fetal Neonatal Med 2018; 4: 1-171
  5. Durand P, Debray D, Mandel R, et al. Acute liver failure in infancy: a 14-year experience of a pediatric liver transplantation center. J Pediatr 2001; 139: 871-6. [Crossref] 13. Demirbas D, Coelho AI, Rubio-Gozalbo ME, Berry GT. Hereditary galactosemia. Metabolism 2018; 83: 188-96. [Crossref] 14. Atik SU, Gürsoy S, Koçkar T, Önal H, Adal SE. Galaktozemi tanılı olgularımızın klinik ve genetik değerlendirilmesi. Turk Arch Pediatr 2016; 51: 204-9. [Crossref] 15. Kishnani PS, Chen YT. Defects in Galactose Metabolism. In: Kleigman RM, Stanton